Hsp27 (HspB1) and αB-crystallin (HspB5) as therapeutic targets AP Arrigo, S Simon, B Gibert, C Kretz-Remy, M Nivon, A Czekalla, ... FEBS letters 581 (19), 3665-3674, 2007 | 421 | 2007 |
Mitochondria: a central target for sex differences in pathologies R Ventura-Clapier, M Moulin, J Piquereau, C Lemaire, M Mericskay, ... Clinical science 131 (9), 803-822, 2017 | 293 | 2017 |
Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment P Geserick, M Hupe, M Moulin, WWL Wong, M Feoktistova, B Kellert, ... Journal of cell biology 187 (7), 1037-1054, 2009 | 284 | 2009 |
IAPs limit activation of RIP kinases by TNF receptor 1 during development M Moulin, H Anderton, AK Voss, T Thomas, WWL Wong, A Bankovacki, ... The EMBO journal 31 (7), 1679-1691, 2012 | 225 | 2012 |
Physiological roles of the permeability transition pore C Brenner, M Moulin Circulation research 111 (9), 1237-1247, 2012 | 222 | 2012 |
Cytotoxic effects induced by oxidative stress in cultured mammalian cells and protection provided by Hsp27 expression AP Arrigo, WJJ Firdaus, G Mellier, M Moulin, C Paul, C Diaz-Latoud, ... Methods 35 (2), 126-138, 2005 | 153 | 2005 |
Sexual dimorphism of doxorubicin-mediated cardiotoxicity: potential role of energy metabolism remodeling M Moulin, J Piquereau, P Mateo, D Fortin, C Rucker-Martin, M Gressette, ... Circulation: Heart Failure 8 (1), 98-108, 2015 | 137 | 2015 |
In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-κB and activation of caspase-8 IE Gentle, WWL Wong, JM Evans, A Bankovacki, WD Cook, NR Khan, ... Journal of Biological Chemistry 286 (15), 13282-13291, 2011 | 101 | 2011 |
Sex differences in exercise-induced physiological myocardial hypertrophy are modulated by oestrogen receptor beta E Dworatzek, S Mahmoodzadeh, C Schubert, C Westphal, J Leber, ... Cardiovascular research 102 (3), 418-428, 2014 | 79 | 2014 |
Knock down of heat shock protein 27 (HspB1) induces degradation of several putative client proteins B Gibert, B Eckel, L Fasquelle, M Moulin, F Bouhallier, V Gonin, G Mellier, ... PLoS One 7 (1), e29719, 2012 | 75 | 2012 |
Muscle redox disturbances and oxidative stress as pathomechanisms and therapeutic targets in early-onset myopathies M Moulin, A Ferreiro Seminars in cell & developmental biology 64, 213-223, 2017 | 63 | 2017 |
Sirtuin 1 regulates pulmonary artery smooth muscle cell proliferation: role in pulmonary arterial hypertension G Zurlo, J Piquereau, M Moulin, JP Da Silva, M Gressette, B Ranchoux, ... Journal of hypertension 36 (5), 1164-1177, 2018 | 56 | 2018 |
Potential roles of membrane fluidity and ceramide in hyperthermia and alcohol stimulation of TRAIL apoptosis M Moulin, S Carpentier, T Levade, AP Arrigo apoptosis 12, 1703-1720, 2007 | 55 | 2007 |
Sex-specific cardiac cardiolipin remodelling after doxorubicin treatment M Moulin, A Solgadi, V Veksler, A Garnier, R Ventura-Clapier, ... Biology of sex differences 6, 1-14, 2015 | 52 | 2015 |
Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires … R Feltham, M Moulin, JE Vince, PD Mace, WWL Wong, H Anderton, ... Journal of Biological Chemistry 285 (23), 17525-17536, 2010 | 46 | 2010 |
Complications of chemotherapy, a basic science update M Mazevet, M Moulin, A Llach-Martinez, C Chargari, É Deutsch, ... La Presse Médicale 42 (9), e352-e361, 2013 | 44 | 2013 |
Defective endoplasmic reticulum-mitochondria contacts and bioenergetics in SEPN1-related myopathy A Filipe, A Chernorudskiy, S Arbogast, E Varone, RN Villar-Quiles, ... Cell Death & Differentiation 28 (1), 123-138, 2021 | 40 | 2021 |
Inducible cardiac-specific deletion of Sirt1 in male mice reveals progressive cardiac dysfunction and sensitization of the heart to pressure overload MN Sanz, L Grimbert, M Moulin, M Gressette, C Rucker-Martin, C Lemaire, ... International journal of molecular sciences 20 (20), 5005, 2019 | 40 | 2019 |
Long lasting heat shock stimulation of TRAIL-induced apoptosis in transformed T lymphocytes M Moulin, AP Arrigo Experimental cell research 312 (10), 1765-1784, 2006 | 36 | 2006 |
TAK1 Is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-κB dependent induction of cFLIPL JM Lluis, U Nachbur, WD Cook, IE Gentle, D Moujalled, M Moulin, ... PLoS One 5 (1), e8620, 2010 | 30 | 2010 |